[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-355892-105":59,"doc-detail-355892-en":135},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":128,"head_meta":130,"extra_data":132,"updated_unix":134},105,"en","integrating-single-cell-transcriptomics-and-machine-learning-to-predict-breast-cancer-prognosis-and-immunotherapy-sensitivity-a-study-based-on-proliferating-t-cells","Integrating single-cell transcriptomics and machine learning to predict breast cancer prognosis and immunotherapy sensitivity - a study based on proliferating T cells","","Breast cancer is a highly prevalent and heterogeneous malignancy where prognosis and treatment remain challenging. The study integrates proliferative T-cell signatures to improve stratification by defining Tprolif-associated risk genes for molecular subtyping and constructing a prognostic model grounded in these subtypes. Single-cell RNA-seq is combined with bulk RNA-seq from TCGA-BRCA and GSE20685, followed by machine-learning risk modeling, cross-dataset validation, gene expression analysis, and in vitro functional testing.",{"@graph":69,"@context":127},[70,84,106],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/integrating-single-cell-transcriptomics-and-machine-learning-to-predict-breast-cancer-prognosis-and-immunotherapy-sensitivity-a-study-based-on-proliferating-t-cells/355892/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/integrating-single-cell-transcriptomics-and-machine-learning-to-predict-breast-cancer-prognosis-and-immunotherapy-sensitivity-a-study-based-on-proliferating-t-cells/355892.png","ImageObject",300,407,{"name":92,"@type":93},"Mimi","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-23","2026-09-22",true,{"@type":102,"interactionType":103,"userInteractionCount":105},"InteractionCounter",{"@type":104},"ViewAction",11,{"@type":107,"mainEntity":108},"FAQPage",[109,115,119,123],{"name":110,"@type":111,"acceptedAnswer":112},"What is the study’s main goal in breast cancer prognosis and immunotherapy response?","Question",{"text":113,"@type":114},"To improve prognostic accuracy by identifying Tprolif-associated risk genes for molecular subtyping and building a prognostic model linked to these subtypes and immunotherapy sensitivity.","Answer",{"name":116,"@type":111,"acceptedAnswer":117},"How are the Tprolif-based molecular subtypes and prognostic model developed?",{"text":118,"@type":114},"Single-cell RNA-seq data from breast cancer are integrated with bulk RNA-seq datasets (TCGA-BRCA and GSE20685) to define Tprolif-based subtypes, then a risk signature is constructed using multiple classical machine-learning algorithms and validated across datasets.",{"name":120,"@type":111,"acceptedAnswer":121},"Which algorithm shows the best prognostic predictive performance and what does it imply?",{"text":122,"@type":114},"The random survival forest (RSF) algorithm demonstrates superior predictive performance by C index. Lower risk scores correspond to a more active immune microenvironment with greater immune cell infiltration.",{"name":124,"@type":111,"acceptedAnswer":125},"What functional experiments support potential therapeutic targets in the study?",{"text":126,"@type":114},"Knockdown experiments targeting MTFR1 and SLC52A2 significantly inhibit breast cancer cell proliferation and migration, supporting their roles as potential therapeutic targets.","https://schema.org",{"og:url":83,"og:type":129,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":131,"canonical":83},"index,follow",{"doc_id":133,"site_id":62},355892,1790142125,{"code":4,"msg":5,"data":136},{"doc_id":133,"user_id":137,"nickname":92,"user_avatar":138,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":139,"file_id":140,"file_url":141,"file_type":142,"file_size":143,"view_count":105,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":56,"language":144,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":145,"faqs":146,"seo_title":147,"seo_description":67,"update_tm":148,"read_time":149,"preview_page_count":19,"preview_urls":150},2336477974920,"https://ap-avatar.wpscdn.com/davatar_155a257f0dc6eb9ab79c44ca47cae57d","Kan etal. World Journal of Surgical Oncology (2026) 24:254  \n[https://doi.org/10.1186/s12957-026-04331-5](https://doi.org/10.1186/s12957-026-04331-5)  \nWorld Journal of Surgical Oncology  \nRESEARCH Open Access  \nIntegrating single-cell transcriptomics and machine learning to predict breast cancer prognosis and immunotherapy sensitivity:  \na study based on proliferating T cells  \nYang Kan1†, Yupeng Xu2†, Shengnan Yao2†, Zhixuan Wu3†, Danni Zheng4* and Jiawei Chen1*  \nAbstract  \nBackground Breast cancer, a highly prevalent and heterogeneous malignancy, poses challenges in prognosis and treatment. Emerging evidence links proliferativeT cells (Tprolif ) to tumor development and progression. This study aims to enhance prognostic accuracy in breast cancer by identifying Tprolif-associated risk genes for molecular subtyping and developing a prognostic model grounded in these subtypes.  \nMethods Single-cell RNA sequencing (scRNA-seq) data from breast cancer samples were integrated with bulk RNA-seq data from theTCGA-BRCA and GSE20685 cohorts to define Tprolif-based molecular subtypes. A prognostic risk signature was constructed using 10 classical machine learning algorithms, with the optimal algorithm  \nselected through performance testing and validated across multiple datasets. The expression of key model genes was analyzed, and their impact on breast cancer cell proliferation and migration was examined through in vitro experiments.  \nResults Three distinct molecular subtypes were identified, each characterized by unique immune cell infiltration profiles and survival outcomes. Using Tprolif-based subtyping and machine learning, the random survival forest (RSF) algorithm exhibited superior predictive performance, as measured by the C index. Patients with lower risk scores demonstrated a more active immune microenvironment with greater immune cell infiltration. Functional assays revealed that knockdown of MTFR1 and SLC52A2 markedly inhibited breast cancer cell proliferation and migration. Conclusion This study underscores the pivotal role ofTprolif cells in breast cancer immune heterogeneity and introduces a robust prognostic model for patient stratification. The identification of molecular subtypes and validation of MTFR1 and SLC52A2 as potential therapeutic targets provide crucial insights for personalized cancer treatment strategies.  \n†Yang Kan, Yupeng Xu, Shengnan Yao and Zhixuan Wu contributed equally and are first authorship.  \n*Correspondence:  \nDanni Zheng [843649928@qq.com](843649928@qq.com)  \nJiawei Chen[chenjw90015@enzemed.com](chenjw90015@enzemed.com)  \nFull list of author information is available at the end of the article  \n© The Author(s) 2026. Open Access This article is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which permits any non-commercial use, sharing, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if you modified the licensed material. You do not have permission under this licence to share adapted material derived from this article or parts of it. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit [http://creati](http://creati)[vecommons.org/licenses/by-nc-nd/4.0/](vecommons.org/licenses/by-nc-nd/4.0/.)[.](vecommons.org/licenses/by-nc-nd/4.0/.)  \nKan et al. World Journal of Surgical Oncology (2026) 24:254 Page 2 of 19  \nKeywords Breast cancer, Proliferating T cells, Machine learning, Tumor microenvironment, Immunotherapy","cbCaiuprPylcGwhc","https://ap.wps.com/l/cbCaiuprPylcGwhc","pdf",26694693,"English","# Abstract\n# Methods\n## Data integration and molecular subtyping\n## Prognostic signature construction and validation\n# Results\n## Molecular subtypes and immune infiltration\n## Predictive performance and risk scoring\n## Functional validation of key genes\n# Conclusion\n# Keywords\n# Introduction","[{\"question\":\"What is the study’s main goal in breast cancer prognosis and immunotherapy response?\",\"answer\":\"To improve prognostic accuracy by identifying Tprolif-associated risk genes for molecular subtyping and building a prognostic model linked to these subtypes and immunotherapy sensitivity.\"},{\"question\":\"How are the Tprolif-based molecular subtypes and prognostic model developed?\",\"answer\":\"Single-cell RNA-seq data from breast cancer are integrated with bulk RNA-seq datasets (TCGA-BRCA and GSE20685) to define Tprolif-based subtypes, then a risk signature is constructed using multiple classical machine-learning algorithms and validated across datasets.\"},{\"question\":\"Which algorithm shows the best prognostic predictive performance and what does it imply?\",\"answer\":\"The random survival forest (RSF) algorithm demonstrates superior predictive performance by C index. Lower risk scores correspond to a more active immune microenvironment with greater immune cell infiltration.\"},{\"question\":\"What functional experiments support potential therapeutic targets in the study?\",\"answer\":\"Knockdown experiments targeting MTFR1 and SLC52A2 significantly inhibit breast cancer cell proliferation and migration, supporting their roles as potential therapeutic targets.\"}]","Integrating single-cell transcriptomics and machine learning to predict breast cancer prognosis and immunotherapy sensitivity - a study based on proliferating T cells | PDF",1790121579,48,[151,155,159,163],{"page_no":8,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/4e7ea172e0505f5209db120ae2e383c4.webp",983,1310,{"page_no":14,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/c8cbccd6436d678ea2236d0a238a503c.webp",982,1309,{"page_no":81,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/fb6cec1dcd950084764121a4ea335a4a.webp",981,1308,{"page_no":19,"url":164,"width":165,"height":166},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/f7d263fff0bdcafadebe8b4931b6cc00.webp",980,1306]